Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

Related Articles by Review for PubMed (Select 21797658)

1.

Corticosteroid use in neurocysticercosis.

Nash TE, Mahanty S, Garcia HH; Cysticercosis Group in Peru.

Expert Rev Neurother. 2011 Aug;11(8):1175-83. doi: 10.1586/ern.11.86. Review.

2.

Diagnosis and treatment of neurocysticercosis.

Nash TE, Garcia HH.

Nat Rev Neurol. 2011 Sep 13;7(10):584-94. doi: 10.1038/nrneurol.2011.135. Review.

3.

Neurocysticercosis: radiologic-pathologic correlation.

Kimura-Hayama ET, Higuera JA, Corona-Cedillo R, Chávez-Macías L, Perochena A, Quiroz-Rojas LY, Rodríguez-Carbajal J, Criales JL.

Radiographics. 2010 Oct;30(6):1705-19. doi: 10.1148/rg.306105522. Review.

PMID:
21071384
4.

Neurocysticercosis: an update.

Carpio A.

Lancet Infect Dis. 2002 Dec;2(12):751-62. Review.

PMID:
12467692
5.

Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?

Romo ML, Carpio A, Kelvin EA.

J Clin Pharmacol. 2014 Apr;54(4):361-7. doi: 10.1002/jcph.269. Epub 2014 Jan 25. Review.

PMID:
24443292
6.

Clinical manifestations, diagnosis, and treatment of neurocysticercosis.

Sotelo J.

Curr Neurol Neurosci Rep. 2011 Dec;11(6):529-35. doi: 10.1007/s11910-011-0226-7. Review.

PMID:
21915772
7.

Corticosteroids for neurocysticercosis: a systematic review and meta-analysis of randomized controlled trials.

Cuello-García CA, Roldán-Benítez YM, Pérez-Gaxiola G, Villarreal-Careaga J.

Int J Infect Dis. 2013 Aug;17(8):e583-92. doi: 10.1016/j.ijid.2012.12.010. Epub 2013 Jan 20. Review.

8.

Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.

Jung-Cook H.

Expert Rev Clin Pharmacol. 2012 Jan;5(1):21-30. doi: 10.1586/ecp.11.72. Review.

PMID:
22142156
9.

Medical management of neurocysticercosis.

Takayanagui OM, Odashima NS, Bonato PS, Lima JE, Lanchote VL.

Expert Opin Pharmacother. 2011 Dec;12(18):2845-56. doi: 10.1517/14656566.2011.634801. Epub 2011 Nov 15. Review.

PMID:
22082143
10.

Medical treatment for neurocysticercosis: drugs, indications and perspectives.

Jung H, Cárdenas G, Sciutto E, Fleury A.

Curr Top Med Chem. 2008;8(5):424-33. Review.

PMID:
18393906
11.

Neurocysticercosis: a review.

Del Brutto OH.

ScientificWorldJournal. 2012;2012:159821. doi: 10.1100/2012/159821. Epub 2012 Jan 4. Review.

12.

Neurocysticercosis.

Del Brutto OH.

Continuum (Minneap Minn). 2012 Dec;18(6 Infectious Disease):1392-416. doi: 10.1212/01.CON.0000423853.47770.90. Review.

PMID:
23221847
13.

Neurocysticercosis.

Del Brutto OH.

Semin Neurol. 2005 Sep;25(3):243-51. Review.

PMID:
16170737
14.

[Neurocysticercosis: up-dating in diagnosis and treatment].

Del Brutto OH.

Neurologia. 2005 Oct;20(8):412-8. Review. Spanish.

PMID:
16217690
15.

[Neurocysticercosis].

del Brutto OH.

Rev Neurol. 1999 Sep 1-15;29(5):456-66. Review. Spanish.

PMID:
10584250
16.

Hypopituitarism caused by neurocysticercosis.

Kelesidis T, Tsiodras S.

Am J Med Sci. 2011 May;341(5):414-6. doi: 10.1097/MAJ.0b013e3182056438. Review.

PMID:
21289508
17.

Anthelmintics for people with neurocysticercosis.

Abba K, Ramaratnam S, Ranganathan LN.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD000215. doi: 10.1002/14651858.CD000215.pub4. Review.

PMID:
20238309
18.

Drug treatment of neurocysticercosis.

Garg RK.

Natl Med J India. 1997 Jul-Aug;10(4):173-7. Review.

PMID:
9325640
19.

Neurocysticercosis.

Del Brutto OH, Garcia HH.

Handb Clin Neurol. 2013;114:313-25. doi: 10.1016/B978-0-444-53490-3.00025-X. Review.

PMID:
23829921
20.

[Treatment of neurocysticercosis: a review].

Nogales-Gaete J, Arriagada C, Salinas R.

Rev Med Chil. 2006 Jun;134(6):789-96. Epub 2006 Aug 14. Review. Spanish.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk